(TBI) TrueBlue - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US89785X1019

TBI EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of TBI over the last 5 years for every Quarter.

TBI Revenue

This chart shows the Revenue of TBI over the last 5 years for every Quarter.

TBI: Contingent Staffing, Recruitment Outsourcing, Workforce Management

TrueBlue Inc. (NYSE:TBI) is a leading provider of specialized workforce solutions across North America, the UK, Australia, and Puerto Rico, operating through three distinct business segments: PeopleReady, PeopleManagement, and PeopleScout. PeopleReady offers contingent staffing services for various industries, including construction, transportation, and manufacturing. PeopleManagement provides on-site industrial staffing and commercial driver services, managing contingent workforces for manufacturing, warehousing, and distribution facilities. PeopleScout delivers recruitment process outsourcing, talent advisory services, and managed service provider solutions, leveraging its proprietary technology platform, Affinix, to source, screen, and onboard talent.

The companys diversified service offerings enable it to cater to a broad range of clients, from construction and transportation to manufacturing and retail. With a history dating back to 1985, TrueBlue has evolved from its origins as Labor Ready, Inc. to become a comprehensive workforce solutions provider. Its expertise in contingent staffing, recruitment process outsourcing, and talent advisory services positions it to capitalize on the growing demand for flexible workforce solutions.

Analyzing the provided , we observe that TBIs stock price has been volatile, with a 52-week high of $12.12 and a low of $3.84. The current price of $5.31 is above its 20-day and 50-day simple moving averages (SMA) of $4.41 and $4.97, respectively, indicating a potential short-term uptrend. However, the stock remains below its 200-day SMA of $7.09, suggesting a longer-term downtrend. The Average True Range (ATR) of 0.42 represents a 7.89% volatility, indicating moderate price fluctuations.

From a fundamental perspective, TrueBlues reveals a market capitalization of $129.40M USD and a forward P/E ratio of 56.18, suggesting that the stock may be overvalued relative to its expected earnings growth. The absence of a trailing P/E ratio and a negative Return on Equity (RoE) of -43.17 indicate that the company has faced significant challenges, potentially related to its business operations or industry conditions.

Combining the insights from both technical and fundamental data, a potential forecast for TrueBlue Inc. could be that the stock may continue to experience volatility in the short term, potentially trading within the range of $4 to $6. However, the long-term outlook remains uncertain due to the companys negative RoE and high forward P/E ratio. To achieve a more accurate forecast, it is essential to closely monitor the companys future earnings reports, industry trends, and overall market conditions. A potential trading strategy could involve buying TBI on dips towards its SMA20 or SMA50, with a stop-loss below the recent lows, targeting a potential upside towards $7-$8, aligning with its 200-day SMA. Nonetheless, this strategy requires continuous monitoring and adjustments based on new information and market dynamics.

Additional Sources for TBI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

TBI Stock Overview

Market Cap in USD 202m
Sector Industrials
Industry Staffing & Employment Services
GiC Sub-Industry Human Resource & Employment Services
IPO / Inception 1996-06-13

TBI Stock Ratings

Growth Rating -71.3
Fundamental -62.4
Dividend Rating 0.0
Rel. Strength -47.5
Analysts 4 of 5
Fair Price Momentum 5.35 USD
Fair Price DCF -

TBI Dividends

Currently no dividends paid

TBI Growth Ratios

Growth Correlation 3m 71.5%
Growth Correlation 12m -77.7%
Growth Correlation 5y -76.4%
CAGR 5y -15.69%
CAGR/Max DD 5y -0.18
Sharpe Ratio 12m 0.40
Alpha -47.28
Beta 0.684
Volatility 59.92%
Current Volume 251k
Average Volume 20d 200.9k
What is the price of TBI shares?
As of June 26, 2025, the stock is trading at USD 6.42 with a total of 251,026 shares traded.
Over the past week, the price has changed by -9.32%, over one month by +4.90%, over three months by +13.83% and over the past year by -37.18%.
Is TrueBlue a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, TrueBlue (NYSE:TBI) is currently (June 2025) a stock to sell. It has a ValueRay Fundamental Rating of -62.37 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TBI is around 5.35 USD . This means that TBI is currently overvalued and has a potential downside of -16.67%.
Is TBI a buy, sell or hold?
TrueBlue has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TBI.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for TBI share price target?
According to our own proprietary Forecast Model, TBI TrueBlue will be worth about 5.9 in June 2026. The stock is currently trading at 6.42. This means that the stock has a potential downside of -7.79%.
Issuer Target Up/Down from current
Wallstreet Target Price 8.3 29.8%
Analysts Target Price 8.3 29.8%
ValueRay Target Price 5.9 -7.8%